bioAffinity Technologies Inc
General ticker "BIAF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $13.3M
bioAffinity Technologies Inc does not follow the US Stock Market performance with the rate: -18.9%.
Estimated limits based on current volatility of 10.2%: low 0.93$, high 1.14$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.03$, 2.39$]
- 2024-12-30 to 2025-12-30 estimated range: [1.07$, 2.45$]
Short-term BIAF quotes
Long-term BIAF plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $2.53MM |
Operating Expenses | $2.21MM | $4.02MM | $10.51MM |
Operating Income | $-2.21MM | $-4.01MM | $-7.97MM |
Non-Operating Income | $-4.12MM | $-4.14MM | $0.06MM |
Interest Expense | $1.00MM | $2.53MM | $0.04MM |
R&D Expense | $1.33MM | $1.29MM | $1.72MM |
Income(Loss) | $-6.32MM | $-8.15MM | $-7.92MM |
Taxes | $0.00MM | $0.00MM | $0.02MM |
Profit(Loss) | $-6.33MM | $-8.15MM | $-7.94MM |
Stockholders Equity | $-15.79MM | $11.04MM | $4.86MM |
Inventory | $0.07MM | $0.01MM | $0.02MM |
Assets | $1.45MM | $12.18MM | $8.22MM |
Operating Cash Flow | $-2.05MM | $-4.07MM | $-6.04MM |
Capital expenditure | $0.00MM | $0.22MM | $0.02MM |
Investing Cash Flow | $0.00MM | $-0.22MM | $-2.21MM |
Financing Cash Flow | $3.33MM | $14.34MM | $-0.34MM |
Earnings Per Share* | $-0.86 | $-1.81 | $-0.91 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.